Skip to main content
main-content

Type 1 diabetes: Continuous glucose monitoring

medwireNews top story

CGM measures have variable correlation with HbA1c

HbA1c

Glycated hemoglobin levels correlate strongly with continuous glucose monitoring-measured average blood glucose and hyperglycemia, but poorly with hypoglycemia, say researchers.

Interactive patient case study

Hypoglycemia and technology

Hypoglycemia and technology

This 15-minute case presents the identification of problematic hypoglycemia and the appropriate use and monitoring of different technologies in the context of reducing the occurrence and risk of hypoglycemia.

Get more on: Hypoglycemia | Devices and technology | Pediatric diabetes

Journal article

Prevention and management of severe hypoglycemia and hypoglycemia unawareness: Incorporating sensor technology

Woman with flash glucose monitor (symbolic image with model)

In this paper, the authors report on the current scientific evidence on the effectiveness of continuous glucose monitoring sensor technology in the prevention of severe hypoglycemia and hypoglycemia unawareness [read more].
Lucidi P et al. Curr Diab Rep 2018; 18: 83. doi: 10.1007/s11892-018-1065-6

Get more on:  Devices and technology | Diabetic complications | Type 1 diabetes

Expert opinion editorial

The right device at the right time: Optimizing the benefit

AdobeStock_64823908

Advisory Board member Katharine Barnard scrutinizes the opinion that clinicians should rely on glycemic outcomes when weighing the decision to prescribe a diabetes device [read more].

Get more on: Devices and technology | Glycemic control in type 1 diabetes | Glycemic control in type 2 diabetes

Case report

Sudden onset of immune-mediated type 1 diabetes mellitus in a 93-year-old woman: A case report

Elderly patient with doctor

Oriot and colleagues report a case of sudden onset autoimmune type 1 diabetes with ketoacidosis in a 93-year-old woman, and summarize the available literature [read more].
Oriot P et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1170-7

Get more on: Flash glucose monitoring | Older adults | Ketoacidosis | Type 1 diabetes medication

Journal article

Glucose control during kidney transplantation in type 1 diabetes patient on sensor augmented pump: a case report

Person holding model kidneys

In this case report, we show the utility of using the sensor augmented pump in the perioperative phase of a patient with type 1 diabetes undergoing an isolated kidney transplantation [read more].
Zivkovic M, Petrovski G, Bitoska I. Acta Diabetol 2018; Advance online publication. doi: 10.1007/s00592-018-1147-6

Get more on: Type 1 diabetes | Devices and technologyGlycemic control

medwireNews editor's pick

CGM may be cost-effective in type 1 diabetes

Piggy bank (healthcare costs)

Analysis of the DIAMOND study shows that continuous glucose monitoring in patients with type 1 diabetes could be considered cost-effective, although this depends on the value for money threshold used.

View from the clinic

Managing patient expectations for glucose management via a device

Doctor having a conversation with a patient

As the utility and availability of devices surges, so too do patient expectations. Advisory Board member Katharine Barnard provides key consultation questions to help determine your patients’ greatest needs and obstacles [read more].

Get more on: Devices and technology | Psychosocial care | Type 1 diabetes | Type 2 diabetes

medwireNews

09-19-2019 | Continuous glucose monitoring | EASD 2019 | News

Majority of MDI users improve glycemic outcomes with CGM

Analysis of the GOLD study suggests that at least three-quarters of people with type 1 diabetes using multiple daily injections benefit from continuous glucose monitoring.

09-17-2019 | Continuous glucose monitoring | EASD 2019 | News

CGM benefits persist with long-term use

The COMISAIR-2 researchers have reported that use of continuous glucose monitoring by people with type 1 diabetes remains high over 3 years, resulting in continued glycemic benefits.

08-27-2019 | Insulin pumps | News

Predictive low-glucose insulin suspend system cuts hypoglycemia in real world

Switching to a predictive low-glucose suspend insulin delivery system significantly reduces hypoglycemia risk in people with diabetes in clinical practice, research shows.

Themed collections

Journal articles and book chapters

08-18-2018 | Continuous glucose monitoring | Review | Article

Prevention and management of severe hypoglycemia and hypoglycemia unawareness: Incorporating sensor technology

Lucidi P et al. Curr Diab Rep 2018; 18: 83. doi: 10.1007/s11892-018-1065-6

08-17-2018 | Insulin pumps | Review | Article

An overview of safety issues on use of insulin pumps and continuous glucose monitoring systems in the hospital

Thompson B et al. Curr Diab Rep 2018; 18: 81. doi: 10.1007/s11892-018-1056-7

06-26-2018 | Devices and technology | Review | Article

Technology in the management of type 1 diabetes mellitus: Current status and future prospects

Tauschmann M Hovorka R. Nat Rev Rheumatol 2018. doi: 10.1038/s41574-018-0044-y

Guidelines

A convenient single access point, providing diabetes professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Slides

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

Practice tips

Practical information, guidance, and helpful resources for diabetes healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within diabetes management, as recommended by our Editorial Board.

Independent Medical Education

Educational programs building upon the most current research and professional practice recommendations, with the aim of enabling more efficient diagnosis, optimizing treatment, and improving patient outcomes.

Image Credits